Clinical Trial Update: EucaLimus Post-Market Registry

View source ↗

Summary

A post-market registry study evaluating EucaLimus in patients with coronary artery disease, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• EucaLimus

Snippet

Sponsor: OrbusNeich | Conditions: Coronary Arterioscleroses | Status: ACTIVE_NOT_RECRUITING